Published in Mol Immunol on February 01, 1989
Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12. J Virol (2003) 1.45
Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis. EMBO J (2007) 1.43
The differential effects of dithiothreitol and 2-mercaptoethanol on the secretion of partially and completely assembled immunoglobulins suggest that thiol-mediated retention does not take place in or beyond the Golgi. Mol Biol Cell (1994) 1.18
Intermolecular disulfide bonding in IgM: effects of replacing cysteine residues in the mu heavy chain. EMBO J (1989) 1.07
High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet (1998) 21.52
Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep (2002) 13.49
Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci U S A (1988) 7.48
Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J (1986) 6.62
PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet (1999) 6.18
Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci U S A (1998) 5.21
Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet (2001) 4.96
Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature (1988) 4.40
Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet (2000) 4.13
Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med (1993) 3.65
The caregiver reaction assessment (CRA) for caregivers to persons with chronic physical and mental impairments. Res Nurs Health (1992) 3.44
Does levodopa accelerate the pathologic process in Parkinson disease brain? Neurology (2011) 3.10
Implementing the patient's charter in outpatient services. BMJ (1992) 2.85
Developmental surveillance in general practice. Br Med J (1978) 2.71
The coding function of nucleotide sequences can be discerned by statistical analysis. J Theor Biol (1981) 2.61
Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences. Proc Natl Acad Sci U S A (1982) 2.44
Deletions in immunoglobulin mu chains. EMBO J (1982) 2.35
Production of functional chimaeric mouse/human antibody. Nature (1985) 2.35
Why the Scots die younger: synthesizing the evidence. Public Health (2012) 2.34
Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet (1998) 2.34
Characterization and organization of DNA sequences adjacent to the human telomere associated repeat (TTAGGG)n. Nucleic Acids Res (1990) 2.23
Members of the olfactory receptor gene family are contained in large blocks of DNA duplicated polymorphically near the ends of human chromosomes. Hum Mol Genet (1998) 2.21
Genome changes and gene expression in human solid tumors. Carcinogenesis (2000) 2.21
Morphological features of TMPRSS2-ERG gene fusion prostate cancer. J Pathol (2007) 2.17
Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells. Proc Natl Acad Sci U S A (1983) 2.03
Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci U S A (1998) 2.02
Non-random association between alleles detected at D4S95 and D4S98 and the Huntington's disease gene. J Med Genet (1989) 1.95
Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res (1994) 1.93
Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant (2001) 1.92
Clinical evaluation of fibreoptic sigmoidoscopy employing the Olympus CF-SB colonoscope. Gut (1971) 1.90
Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res (1996) 1.89
Homologous recombination in hybridoma cells: dependence on time and fragment length. Mol Cell Biol (1990) 1.89
The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res (1998) 1.88
Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol (1998) 1.84
Properties of recombination-deficient mutants of bacteriophage lambda. J Mol Biol (1970) 1.80
Providing the ideal surgical service. Ann R Coll Surg Engl (1992) 1.74
Homologous recombination can restore normal immunoglobulin production in a mutant hybridoma cell line. Proc Natl Acad Sci U S A (1988) 1.70
Analysis of nucleotide sequences of two ligninase cDNAs from a white-rot filamentous fungus, Phanerochaete chrysosporium. Gene (1987) 1.67
Acute gastroenteritis in northern Ireland and the Republic of Ireland: a telephone survey. Commun Dis Public Health (2004) 1.66
Surgical training, supervision, and service. BMJ (1999) 1.65
Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res (1998) 1.61
Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients. J Clin Invest (1985) 1.59
Mutations affecting the structure and function of immunoglobulin M. Mol Cell Biol (1982) 1.58
Immunoglobulin production by lymphocyte hybridomas. Eur J Immunol (1978) 1.56
Transposition of two different intracisternal A particle elements into an immunoglobulin kappa-chain gene. Mol Cell Biol (1984) 1.55
Electron microscopy for the diagnosis of cutaneous viral infections. Br J Dermatol (1970) 1.55
Gene replacement with one-sided homologous recombination. Mol Cell Biol (1992) 1.51
Transfer of a cloned immunoglobulin light-chain gene to mutant hybridoma cells restores specific antibody production. Nature (1983) 1.51
Cardiovascular risk factor changes in the Kilkenny Health Project. A community health promotion programme. Eur Heart J (1995) 1.49
Small margin excision of periocular basal cell carcinoma: 5 year results. Br J Ophthalmol (2004) 1.48
Frozen-thawed transfer cycles: are they comparable with fresh? Ir Med J (2008) 1.45
Bacteriological survey of tuberculous lymphadenitis in South-east England: 1973-80. J Epidemiol Community Health (1982) 1.42
Preventing HIV infection. Sci Am (1998) 1.39
IgM--molecular requirements for its assembly and function. Immunol Today (1989) 1.38
Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res (1995) 1.38
Organisation of acute general hospital services: a surgical synopsis of the JCC document. Ann R Coll Surg Engl (2000) 1.38
Use of selected vitamin and mineral supplements among individuals infected with human immunodeficiency virus. J Am Diet Assoc (1991) 1.38
Prevalence and correlates of HIV testing in a multi-site sample of young men who have sex with men. AIDS Care (2008) 1.36
Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG (2008) 1.33
ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis. Oncogene (1997) 1.31
Anticoagulant patient information material is written at high readability levels. Stroke (2000) 1.29
Frequency of alcohol use and its association with STD/HIV-related risk practices, attitudes and knowledge among an African-American community-recruited sample. Int J STD AIDS (1998) 1.27
Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer (1999) 1.25
A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis. Genomics (1995) 1.24
Strategies to minimize attrition in longitudinal studies. Nurs Res (1990) 1.20
New att mutants of phage lambda. Virology (1976) 1.20
Voluntary counseling, testing, and referral for HIV: new technologies, research findings create dynamic opportunities. J Acquir Immune Defic Syndr (2000) 1.20
A brain-death protocol. Lancet (1980) 1.19
Interaction of the microtubule cytoskeleton with endocytic vesicles and cytoplasmic dynein in cultured rat hepatocytes. J Biol Chem (1995) 1.14
On the linkage between RNA processing and RNA translatability. J Biol Chem (1994) 1.14
B and T cells are not required for the viable motheaten phenotype. J Exp Med (1996) 1.14
Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty. Transfus Med (2007) 1.12
On the structure of polymeric IgM. Eur J Immunol (1988) 1.11
Relation between sexual abuse in childhood and adult depression: case-control study. BMJ (1998) 1.11
Polyamine levels in petunia genotypes with normal and abnormal floral morphologies. Plant Physiol (1988) 1.10
Double blind: double talk or are there ways to do better research. Med Hypotheses (1986) 1.09
Complement activation is required for IgM-mediated enhancement of the antibody response. J Exp Med (1988) 1.08
Analysis of T lymphocytes cloned from the synovial fluid and blood of a patient with Lyme arthritis. Int Immunol (1990) 1.08
Connective tissue abnormalities in MRL/1 mice. Ann Rheum Dis (1986) 1.08
Intermolecular disulfide bonding in IgM: effects of replacing cysteine residues in the mu heavy chain. EMBO J (1989) 1.07
Is bovine, atypical or resistant tuberculosis a problem? Ir Med J (1987) 1.07
Isolation of lymphocytes from normal adult human liver suitable for phenotypic and functional characterization. J Immunol Methods (2000) 1.07
Analysis of hybridoma mutants defective in synthesis of immunoglobulin M. Somat Cell Mol Genet (1986) 1.06
Combined 5-fluorouracil and irradiation for transitional cell carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys (1990) 1.06
Endoscopic laser treatment of vascular anomalies of the upper gastrointestinal tract. Gut (1985) 1.05
Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes. J Cell Sci (1993) 1.03
Nucleotide sequences of immunoglobulin mu heavy chain deletion mutants. Nucleic Acids Res (1983) 1.03
Variegated expression of the endogenous immunoglobulin heavy-chain gene in the absence of the intronic locus control region. Mol Cell Biol (1999) 1.03
Genomic organization and complete sequence of the human gene encoding the beta-subunit of the cGMP phosphodiesterase and its localisation to 4p 16.3. Nucleic Acids Res (1991) 1.03
Cellular and molecular restrictions of the lymphocyte fusion. Curr Top Microbiol Immunol (1978) 1.02
Influence of dose and duration of infusion of interleukin-2 on toxicity and immunomodulation. J Clin Oncol (1988) 1.02
Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial. Cancer Res (1987) 1.02
A hit-and-run system for introducing mutations into the Ig H chain locus of hybridoma cells by homologous recombination. J Immunol (1993) 1.02
Molecular cytogenetics of human breast cancer. Cold Spring Harb Symp Quant Biol (1994) 1.02
A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH. Oncogene (2006) 1.01
Health literacy and numeracy. JAMA (1999) 1.01
Homologous recombination between transferred and chromosomal immunoglobulin kappa genes. Mol Cell Biol (1988) 1.01
Interchromosomal recombination is suppressed in mammalian somatic cells. EMBO J (1995) 1.01